Physician profile
Marilyn Appiah
NPI 1194757963
$4,118.74
in general payments reported to CMS, 2019-2025
31 companies · $6.99 in 2025
The $6.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $660 · 2021: $1,116 · 2022: $617 · 2023: $394 · 2024: $552 · 2025: $6.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,590.63 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $363.74 | 2022-2024 | |
| Pfizer INC. | $249.67 | 2019-2023 | |
| Organon LLC | $227.15 | 2021-2025 | Jada System |
| Merck Sharp & Dohme LLC | $165.46 | 2019-2024 | Gardasil, Gardasil 9 |
| Lupin INC. | $150.49 | 2019-2020 | |
| Exeltis, USA INC. | $128.36 | 2021-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $106.78 | 2019-2022 | |
| Therapeuticsmd, INC. | $104.55 | 2019-2021 | |
| Gynesonics, INC. | $78.39 | 2021 | |
| Hologic Sales and Service, LLC | $77.08 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Intuitive Surgical, INC. | $75.31 | 2019 | |
| Sage Therapeutics, LLC | $73.90 | 2020-2024 | |
| Evofem Biosciences, INC. | $71.90 | 2021-2022 | |
| Avion Pharmaceuticals | $69.43 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $67.35 | 2021-2024 | Twirla |
| Allergan, INC. | $64.41 | 2019-2020 | |
| Ethicon US, LLC | $55.84 | 2022-2024 | Ethicon, Stratafix, Dermabond Prineo |
| Myovant Sciences INC. | $51.81 | 2022 | |
| Sumitomo Pharma America, INC. | $50.74 | 2024 | Myfembree |
| Exact Sciences Corporation | $50.63 | 2023-2024 | Cologuard Collection Kit |
| Minerva Surgical, INC | $42.15 | 2023 | |
| Mission Pharmacal Company | $38.11 | 2019-2021 | |
| Millicent US INC | $31.89 | 2020-2024 | Femring, Intrarosa |
| Astellas Pharma US INC | $31.31 | 2023 | Veozah |
| Pacira Pharmaceuticals Incorporated | $26.46 | 2020 | |
| Ascend Therapeutics US, LLC | $17.60 | 2020 | |
| Roche Diagnostics Corporation | $16.90 | 2021 | |
| Meditrina | $16.88 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.19 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Appiah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.